Teaching an old pathway new tricks: Targeting BTK to block NLRP3

Article Tools

• Email

  Thank you for your interest in spreading the word about Science Immunology.

  NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

  Your Email

  Your Name

  Send To

  Enter multiple addresses on separate lines or separate them with commas.

  You are going to email the following Teaching an old pathway new tricks: Targeting BTK to block NLRP3

  Message Subject (Your Name) has forwarded a page to you from Science Immunology

  Message Body (Your Name) thought you would like to see this page from the Science Immunology web site.

  Your Personal Message

  Send Message
• Save to my folders

  User Name

  Password

  Remember my user name & password.

  Submit
• Alerts

  Please log in to add an alert for this article.

  Username Enter your Sciencemag.org username.

  Password Enter the password that accompanies your username.

  Log in
• Citation tools

  Teaching an old pathway new tricks: Targeting BTK to block NLRP3

  By Sarah E. Henrickson

  Science Immunology03 Nov 2017

  A proteomics screen identified BTK as a novel inflammasome regulator and demonstrated that blocking BTK can inhibit inflammasome activity.

  Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
• Share

  Teaching an old pathway new tricks: Targeting BTK to block NLRP3

  By Sarah E. Henrickson

  Science Immunology03 Nov 2017

  A proteomics screen identified BTK as a novel inflammasome regulator and demonstrated that blocking BTK can inhibit inflammasome activity.

  Share This Article: Copy